These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29759932)

  • 21. Developmental programming in human umbilical cord vein endothelial cells following fetal growth restriction.
    Terstappen F; Calis JJA; Paauw ND; Joles JA; van Rijn BB; Mokry M; Plösch T; Lely AT
    Clin Epigenetics; 2020 Nov; 12(1):185. PubMed ID: 33256815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology.
    Stanek J
    Virchows Arch; 2016 Jun; 468(6):723-32. PubMed ID: 26983702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal and neonatal outcomes of preterm infants born before 32 weeks of gestation according to antenatal vs postnatal assessments of restricted growth.
    Monier I; Ancel PY; Ego A; Jarreau PH; Lebeaux C; Kaminski M; Goffinet F; Zeitlin J;
    Am J Obstet Gynecol; 2017 May; 216(5):516.e1-516.e10. PubMed ID: 28188770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of 2 204 stillbirths in 11 hospitals of Guangdong province].
    Yu L; Tang M; Fan XH; Du HM; Tang H; Chen P; Xing SL; Su CH; Chen DJ
    Zhonghua Fu Chan Ke Za Zhi; 2017 Dec; 52(12):805-810. PubMed ID: 29325263
    [No Abstract]   [Full Text] [Related]  

  • 25. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.
    Melamed N; Baschat A; Yinon Y; Athanasiadis A; Mecacci F; Figueras F; Berghella V; Nazareth A; Tahlak M; McIntyre HD; Da Silva Costa F; Kihara AB; Hadar E; McAuliffe F; Hanson M; Ma RC; Gooden R; Sheiner E; Kapur A; Divakar H; Ayres-de-Campos D; Hiersch L; Poon LC; Kingdom J; Romero R; Hod M
    Int J Gynaecol Obstet; 2021 Mar; 152 Suppl 1(Suppl 1):3-57. PubMed ID: 33740264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental insufficiency among high-risk pregnancies with a normal umbilical artery resistance index after 32weeks.
    Geerts L; Van der Merwe E; Theron A; Rademan K
    Int J Gynaecol Obstet; 2016 Oct; 135(1):38-42. PubMed ID: 27515046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suspected Fetal Growth Restriction at 37 Weeks: A Comparison of Doppler and Placental Pathology.
    Curtin WM; Millington KA; Ibekwe TO; Ural SH
    Biomed Res Int; 2017; 2017():3723879. PubMed ID: 28409154
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction.
    Kaitu'u-Lino TJ; MacDonald TM; Cannon P; Nguyen TV; Hiscock RJ; Haan N; Myers JE; Hastie R; Dane KM; Middleton AL; Bittar I; Sferruzzi-Perri AN; Pritchard N; Harper A; Hannan NJ; Kyritsis V; Crinis N; Hui L; Walker SP; Tong S
    Nat Commun; 2020 May; 11(1):2411. PubMed ID: 32415092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes.
    Spiel M; Salahuddin S; Pernicone E; Zsengeller Z; Wang A; Modest AM; Karumanchi SA; Hecht JL
    Placenta; 2017 Apr; 52():10-16. PubMed ID: 28454690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated approach to fetal growth restriction.
    Figueras F; Gratacos E
    Best Pract Res Clin Obstet Gynaecol; 2017 Jan; 38():48-58. PubMed ID: 27940123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic imbalances in the placenta are associated with poor fetal growth.
    Del Gobbo GF; Yin Y; Choufani S; Butcher EA; Wei J; Rajcan-Separovic E; Bos H; von Dadelszen P; Weksberg R; Robinson WP; Yuen RKC
    Mol Med; 2021 Jan; 27(1):3. PubMed ID: 33413077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stillbirth at term: Does size really matter?
    Coutinho CM; Melchiorre K; Thilaganathan B
    Int J Gynaecol Obstet; 2020 Sep; 150(3):299-305. PubMed ID: 32438457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stillbirth Following Normal Ultrasound Findings and Maternal Placental Growth Factor Levels.
    Chandran AR; Agrawal S; Hobson SR; Windrim RC; Parks T; Kingdom JC
    J Obstet Gynaecol Can; 2021 Dec; 43(12):1426-1428. PubMed ID: 34411727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of adverse perinatal outcome by cerebroplacental ratio adjusted for estimated fetal weight.
    Sirico A; Diemert A; Glosemeyer P; Hecher K
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):381-386. PubMed ID: 28294442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic insights into the development of severe fetal growth restriction.
    Gumina DL; Su EJ
    Clin Sci (Lond); 2023 Apr; 137(8):679-695. PubMed ID: 37186255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early- versus Late-Onset Fetal Growth Restriction Differentially Affects the Development of the Fetal Sheep Brain.
    Alves de Alencar Rocha AK; Allison BJ; Yawno T; Polglase GR; Sutherland AE; Malhotra A; Jenkin G; Castillo-Melendez M; Miller SL
    Dev Neurosci; 2017; 39(1-4):141-155. PubMed ID: 28273661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classifying neonatal growth outcomes: use of birth weight, placental evaluation and individualized growth assessment.
    Deter RL; Levytska K; Melamed N; Lee W; Kingdom JC
    J Matern Fetal Neonatal Med; 2016 Dec; 29(24):3939-49. PubMed ID: 26998592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clustering and classical analysis of clinical and placental phenotypes in fetal growth restriction and constitutional fetal smallness.
    Stanek J; Biesiada J
    Placenta; 2016 Jun; 42():93-105. PubMed ID: 27238719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth.
    Hannan NJ; Stock O; Spencer R; Whitehead C; David AL; Groom K; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Gordon L; Beard S; Chindera K; Karegodar S; Hiscock R; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Tong S
    BMC Med; 2020 May; 18(1):145. PubMed ID: 32438913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Femur development in fetal growth restriction as observed on prenatal magnetic resonance imaging.
    Nemec SF; Schwarz-Nemec U; Prayer D; Weber M; Bettelheim D; Kasprian G
    Ultrasound Obstet Gynecol; 2023 May; 61(5):601-609. PubMed ID: 36445348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.